Startup Origin Genomics urges reconsideration of gene-edited babies ban

Origin Genomics is advocating for a reevaluation of the current legal prohibitions on creating gene-edited babies. The company argues that the potential benefits of editing disease-causing genes in human embryos may outweigh the associated risks, marking a significant moment in the debate over genetic technology and ethics.

Originally published by npr